Wearable drug delivery IoT platform supports continuous therapy monitoring
The new concept integrates connectivity with a modular drug delivery platform and enables continuous monitoring of the therapy with the help of a single use liquid flow sensor for safe ambulatory treatments. Sensirion’s cost-effective LD20 single-use liquid flow sensor used for this concept study, is very compact and measures flow rates in the micro and millilitre per hour range with outstanding precision and reliability thanks to patented CMOSens Technology. Additionally, it features sensitive failure detection mechanisms to help counteract, for example, occlusions and air-in-line. Quantex’ pump design is based on a rotary, fixed displacement principle thus is much less sensitive to variables such as line pressure, fluid viscosity and flow rate. The compactness, low power consumption and cost-effectiveness of both, sensor and pump, allow the design of a wearable device which controls and monitors the drug delivery therapy simultaneously. Such a connected drug delivery platform opens up entirely new possibilities for all involved stakeholders. While patients and clinicians benefit from an increased ease of use and confidence in the therapy, low maintenance and less training efforts; it allows healthcare and pharma companies to capture vital adherence data and simplifies patient compliance.
Sensirion – www.sensirion.com
Quantex – www.quantex-arc.com
If you enjoyed this article, you will like the following ones: don't miss them by subscribing to :
